Picard Medical, Inc. Announces Presentation at H.C. Wainwright Global Investment Conference

Rhea-AI Summary

Picard Medical (NYSE American: PMI) announced its upcoming participation in the H.C. Wainwright 27th Annual Global Investment Conference. The event will be held from September 8-10, 2025, at the Lotte New York Palace Hotel in a hybrid format featuring both in-person and virtual sessions.

CEO Patrick NJ Schnegelsberg will deliver an in-person company presentation on September 10th at 1:30 pm. The presentation will be webcasted live and available for replay through Picard's website in the Investor Overview/Events section.

News Market Reaction – PMI

+13.85% 2.0x vol

16 alerts

+13.85% Session close to close

+10.1% Peak in 10 hr 13 min

$487.83M Market Cap

2.0x Rel. Volume

In the Sep 8 session, PMI gained 13.85%, reflecting a significant positive market reaction. Argus tracked a peak move of +10.1% during that session. Our momentum scanner triggered 16 alerts that day, indicating notable trading interest and price volatility. Trading volume was elevated at 2.0x the daily average, suggesting notable buying interest.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

TUCSON, Ariz., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), today announced that Patrick NJ Schnegelsberg, Chief Executive Officer, will present in-person at the H.C. Wainwright 27^th Annual Global Investment Conference being held both in-person and virtually from September 8 -10, 2025 at the Lotte New York Palace Hotel.

Presentation information is below:

H.C. Wainwright Annual Global Investment Conference

Presentation date: September 10th
Presentation time: 1:30 pm
Format: in-person; live, webcasted Company presentation with reply

To listen to the presentation live or via replay, please visit the Investor Overview/Events section of the Picard website here

About Picard Medical, Inc.

Picard Medical, Inc. is the parent company of SynCardia Systems, LLC (“SynCardia”), the Tucson, Arizona–based leader with the only commercially available total artificial heart technology for patients with end-stage heart failure. SynCardia develops, manufactures, and commercializes the SynCardia Total Artificial Heart (“STAH”), an implantable system that assumes the full functions of a failing or failed human heart. It is the first artificial heart approved by both the FDA and Health Canada, and it remains the only commercially available artificial heart in the United States and Canada. With more than 2,100 implants performed at hospitals across 27 countries, the SynCardia Total Artificial Heart is the most widely used and extensively studied artificial heart in the world. For more information, please visit https://www.syncardia.com.

Contact:

Investors

Eric Ribner
Managing Director
LifeSci Advisors LLC
eric@lifesciadvisors.com

Picard Medical, Inc./SynCardia Systems, LLC
IR@picardmedical.com

General/Media

Brittany Lanza
blanza@syncardia.com

FAQ

When is Picard Medical (PMI) presenting at the H.C. Wainwright Conference 2025?

Picard Medical will present on September 10th, 2025 at 1:30 pm at the Lotte New York Palace Hotel.

Who will represent Picard Medical at the H.C. Wainwright Conference?

Patrick NJ Schnegelsberg, the Chief Executive Officer of Picard Medical, will deliver the company presentation.

How can investors access Picard Medical's H.C. Wainwright Conference presentation?

Investors can access the live presentation and replay through the Investor Overview/Events section of Picard Medical's website.

What type of format will Picard Medical's presentation have at the conference?

The presentation will be delivered in-person and will be webcasted live with replay availability.